Canada· CA-DIN-02315890
REFRESH EYE ALLERGY RELIEF
A naphazolin, kombinationen product containing antazoline phosphate + naphazoline hydrochloride, registered in Canada by ABBVIE CORPORATION. The same ATC class is registered in 6 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Naphazolin, kombinationen is registered in 6 of 19 countries.
Countries holding a registration under ATC S01GA51 (naphazolin, kombinationen), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 3 of them publish a price we can compare per daily dose
Naphazolin, kombinationen · ATC S01GA51
6 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Ireland
- Polandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- ANTAZOLINE PHOSPHATE + NAPHAZOLINE HYDROCHLORIDE
- Manufacturer
- ABBVIE CORPORATION
- Country
- Canada (CA)
- ATC code
- S01GA51
- ATC class
- Naphazolin, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Naphazolin, kombinationen in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainALERGOFTAL 0,25 mg/ml+ 5 mg/ml COLIRIO EN SOLUCIONReva Health Europe S.L.
- CzechiaSANORIN COMBIFARMAK INTERNATIONAL Sp.z.o.o., Varšava
- FinlandAntistin-PrivinNovartis Healthcare A/S
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Czechia · Sanorin Combi
- Spain · Alergoftal, Optialerg
- Portugal · Alergiftalmina
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d3c38ee4-c31f-4bde-8fa8-080309c1cc9a GET /v1/drugs/d3c38ee4-c31f-4bde-8fa8-080309c1cc9a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02315890",
"form": "SOLUTION",
"class": "Human",
"routes": [
"OPHTHALMIC"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "S01GA51",
"schedule": [
"OTC"
],
"drug_code": "80140",
"strengths": [
"0.51 %",
"0.051 %"
],
"ahfs_class": null,
"substances": [
"ANTAZOLINE PHOSPHATE",
"NAPHAZOLINE HYDROCHLORIDE"
],
"product_categorization": null
}See everything about naphazolin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.